REDUCEDT+30
Amylyx Pharmaceuticals Inc · NASDAQ
−29,545 sh · $950.0K
Filed 14 Sept 2026SEC Form 4view source
- REDUCEDT+30
Amylyx Pharmaceuticals Inc · NASDAQ
−919 sh · $30.5K
Filed 14 Sept 2026SEC Form 4view source - ACQUIREDStale
Amylyx Pharmaceuticals Inc · NASDAQ
+60,039 sh
Filed 20 Aug 2026SEC Form 4view source